Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Perinatol ; 41(13): 1803-1807, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-38301723

RESUMO

OBJECTIVE: This study aimed to elucidate factors contributing to uptake of highly effective contraception, including permanent contraception, and no contraceptive plan among postpartum people with HIV (PWHIV). STUDY DESIGN: A retrospective cohort analysis was conducted to correlate postpartum birth control (PPBC) with sociodemographic and biomedical variables among postpartum PWHIV who received care at The Ruth M. Rothstein CORE Center and delivered at John H. Stroger, Jr. Hospital of Cook County in Chicago, from 2012 to 2020. RESULTS: Earlier gestational age (GA) at initiation of prenatal care, having insurance, and increased parity are associated with uptake of highly effective contraception. Meanwhile, later GA at presentation increased odds of having no PPBC plan. CONCLUSION: Early prenatal care, adequate insurance coverage, and thorough PPBC counseling are important for pregnant PWHIV. KEY POINTS: · Contraceptive use among PWHIV is poorly understood.. · Having insurance and increased parity are associated with long-acting reversible contraception use.. · Earlier GA at first prenatal care visit is associated with increased PPBC uptake..


Assuntos
Comportamento Contraceptivo , Infecções por HIV , Contracepção Reversível de Longo Prazo , Período Pós-Parto , Centros de Atenção Terciária , Humanos , Feminino , Estudos Retrospectivos , Adulto , Gravidez , Contracepção Reversível de Longo Prazo/estatística & dados numéricos , Comportamento Contraceptivo/estatística & dados numéricos , Cuidado Pré-Natal , Adulto Jovem , Idade Gestacional , Chicago , Cobertura do Seguro , Paridade , Anticoncepção/estatística & dados numéricos , Complicações Infecciosas na Gravidez
2.
Ment Health Clin ; 11(5): 301-304, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34621607

RESUMO

We present a case in which a patient developed fever and leukocytosis subsequent to each monthly haloperidol decanoate injection, an adverse reaction that does not meet the diagnostic criteria of neuroleptic malignant syndrome (NMS) or any previously reported adverse reaction for this medication. A patient being treated with haloperidol decanoate for psychosis experienced a fever within 3 days of injection and leukocytosis along with swelling, pain, and a "knot" feeling at the injection site. This recurred after each injection for several months. Muscle rigidity or changes in vital signs other than temperature were not noted. Temperature and injection site reactions resolved with administration of acetaminophen and ibuprofen. The elevation in temperature was discovered as a result of universal twice daily temperature monitoring implemented due to the COVID-19 pandemic. Reports of fever with antipsychotics are typically associated with NMS or heat stroke; the details of this case do not meet the clinical criteria for either. Similar reactions are reported for other antipsychotics, such as clozapine and olanzapine, but not for haloperidol. The recommendation was to discontinue use of the medication due to an unclear mechanism of the reaction.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA